Standard Fees

Description

Annual Director Retainer

- Stock Component

- $160,000 valuation

- Issued pursuant to the Company’s 2022 Long-Term Incentive Plan (the “2022 Plan”)

- Cash Component

- $105,000

Committee Chair Annual Retainer (amount includes Committee Annual Retainer)

- $25,000 for the Chair of the Nominating and Corporate Governance Committee

- $30,000 for the Chair of the Compensation and Human Capital Committee

- $36,000 for the Chair of the Audit Committee

Chair of the Board Retainer

- $135,000

Committee Annual Retainer

- $10,000 for each member of the Nominating and Corporate Governance Committee (excluding the Committee Chair)

- $11,000 for each member of the Compensation and Human Capital Committee (excluding the Committee Chair)

- $15,000 for each member of the Audit Committee (excluding the Committee Chair)

Deferred Compensation Plan

- Directors may defer receipt of their cash and stock compensation (including any cash compensation that is converted into stock under the Conversion Program). Deferred cash amounts are accrued in a memorandum account that is credited with interest derived from the so-called General Agreement on Tariffs and Trade (GATT) Rate (4.54% for 2025). All deferrals are pursuant to The Hanover Insurance Group, Inc. Non-Employee Director Deferral Plan

Conversion Program

- At the election of each director, cash retainers may be converted into Common Stock of the Company with such stock issued pursuant to the 2022 Plan

Reimbursable Expenses

- Travel and related expenses incurred in connection with service on the Board of Directors and its Committees

Matching Charitable Contributions

- Company will provide matching contributions to qualified charitable organizations up to $5,000 per director per year